维普中文期刊产品整合服务
221篇 您的检索式:作者名="Zhang DR"
    题名 作者 年代 出处 被引量
1Δ4-3-oxosteroid-5β-reductase deficiency: Responses to oral bile acid therapy and long-term outcomes显示文摘BACKGROUND Disorders of primary bile acid synthesis may be life-threatening if undiagnosed,or not treated with primary bile acid replacement therapy. To date, there are few reports on the management and follow-up of patients with Δ4-3-oxosteroid 5β-reductase(AKR1 D1) deficiency. We hypothesized that a retrospective analysis of the responses to oral bile acid replacement therapy with chenodeoxycholic acid(CDCA) in patients with this bile acid synthesis disorder will increase our understanding of the disease progression and permit evaluation of this treatment regimen as an alternative to the Food and Drug Administration(FDA) approved drug cholic acid, which is currently unavailable in China.AIM To evaluate the therapeutic responses of patients with AKR1 D1 deficiency to oral bile acid therapy, specifically CDCA.METHODS Twelve patients with AKR1 D1 deficiency, confirmed by fast atom bombardment ionization-mass spectrometry analysis of urine and by gene sequencing for mutations in AKR1 D1, were treated with differing doses of CDCA or ursodeoxycholic acid(UDCA). The clinical and biochemical responses to therapy were monitored over a period ranging 0.5-6.4 years. Dose adjustment, to optimize the therapeutic dose, was based on changes in serum biochemistry parameters,notably liver function tests, and suppression of the urinary levels of atypical hepatotoxic 3-oxo-Δ4-bile acids measured by mass spectrometry.RESULTS Physical examination, serum biochemistry parameters, and sonographic findings improved in all 12 patients during bile acid therapy, except one who underwent liver transplantation. Urine bile acid analysis confirmed a significant reduction in atypical hepatotoxic 3-oxo-Δ4 bile acids concomitant with clinical and biochemical improvements in those patients treated with CDCA. UDCA was ineffective in down-regulating endogenous bile acid synthesis as evidenced from the inability to suppress the urinary excretion of atypical 3-oxo-Δ4-bile acids. The dose of CDCA required for optimal clinical and biochemical responses varied from 5.5-10 mg/kg per day among patients based on maximum suppression of the atypical bile acids and improvement in serum biochemistry parameters, and careful titration of the dose was necessary to avoid side effects from CDCA.CONCLUSION The primary bile acid CDCA is effective in treating AKR1 D1 deficiency but the therapeutic dose requires individualized optimization. UDCA is not recommended for long-term management.Mei-Hong Zhang Kenneth DR Setchell Jing Zhao Jing-Yu Gong Yi Lu Jian-She Wang 2019World Journal of Gastroenterology2019,25,7:7
2Disseminated malignant solitary fibrous tumor of the pleura 显示文摘Zhang HQ Lucas DR Pass HI 2004Pathol int2004,54,2:1
3Examination of POU homeobox gene expression in human breast cancer cells显示文摘 Branch DR Zhang XY 1999Int J Cancer1999,81,:1
4Hematocrit and the risk of cardiovascular disease-the Framingham study: a 34-year follow-up显示文摘Gagnon DR Zhang TJ Brand FN 1994Am Heart J1994,127,3:1
5Detction of enterovirus capsid protein VP1 in myocardium from cases of myocarditis or dilated cardiomyopathy by immunohistochemistry: future evidence of enterovirus persistence in myocytes 显示文摘Zhang H Li Y McClean DR 2004Medical Microbiology & Immunology2004,193,23:1
6Disseminated malignant solitary fibrous tumor of the pleura显示文摘Zhang H Lucas DR Pass HI 2004Pathol Int2004,54,2:1
7Semaphorin 3B is a 1,25-Dihydroxyvitamin D3-induced gene in osteoblasts that promotes osteoclastogenesis and induces osteopenia in mice显示文摘Sutton AL Zhang X Dowd DR 2008Mol Endocrinol2008,22,6:1
8Disseminated malignant solitary fibrous tumor of the pleura显示文摘Zhang H Lucas DR Pass HI 2004Pathol Int2004,54,2:1
9Liver cell specific targeting of peptide nucleic acid oligomers to inhibit the telomerase activity显示文摘Zhang X Simmons CG Corey DR 2001Bioorg Med Chem Lett2001,11,:1
10fMRI revealed neural substrate for reversible working memory dysfunction in subclinical hypothyroidism 显示文摘Zhu DF Wang ZX Zhang DR 2006Brain2006,129,11:1
11Hematocrit and the risk of cardiovascular disease-the Framingham study:a 34-year follow-up显示文摘Gagnon DR Zhang TJ Brand FN 1994Am Heart J1994,127,3:1
12The homeobox gene GLABRA2 is required for position-dependent cell differentiation in the root epidermis of Arabidopsis thaliana显示文摘Masucci JD Rerie WG Foreman DR Zhang M Galway ME Marks MD Schiefelbein JW 1996Development1996,122,4:1
13B lymphocytes from early vertebrates have potent phagocytic and microbicidal abilities显示文摘Li J Barreda DR Zhang YA 2006Nature Immunology2006,7,10:1
14Progress in research into the mech- anism of radix salviae mihiorrhizae in treatment of acute pan- creatitis 显示文摘Zhang XP Li ZJ Liu DR 2006Hepatobiliary Pancreat Dis Int2006,5,4:1
15Drug nanocrystals for the formulation of poorly soluble drugs and its application as a potential drug delivery system 显示文摘Gao L Zhang DR Chen MH 2008J Nanoparticle Res2008,10,5:1
16Apoptosis in astrocytomas with different grades of malignancy显示文摘Yew DT Wang HH Zhang DR 1998Acta Neurochir (wien)1998,140,3:1
17Indirect detection of protein-metal binding:interaction of serum transferrin with In3 + and Bi3+显示文摘Zhang MX Gumerov DR Kaltashov IA 2004AM Soc Mass Spectrom2004,15,:1
18Defect characterization using an ultrasonic array to measure the scattering coefficient matrix 显示文摘ZHANG J DR/NKWATER B W WILCOX P D 2008IEEE Transactions on Ultrasonics Ferroelectrics and Frequency Control2008,55,10:1
19Improved cathode materials for microbial electrosynthesis 显示文摘Zhang T Nie H Bain TS Lu H Cui M Snoeyenbos-West OL Franks AE Nevin KP Russell TP Lovley DR 2012Energy Environ Sci2012,6,1:1
20Expression of eukaryotic proteins in soluble form in Escherichia coli显示文摘ZHANG Y OLSEN DR NGUYEN KB 1998Pro- tein Expr Purif1998,12,2:1
返回顶部 每页显示:
共12页 首页 上一页 第1页 下一页 末页 /12 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费